Search

Andrew M Camilli

from Sharon, MA
Age ~61

Andrew Camilli Phones & Addresses

  • 5 Moose Hill Pkwy, Sharon, MA 02067 (781) 793-9004
  • Chestnut Hill, MA
  • Canton, MA
  • Flint, MI
  • Drexel Hill, PA
  • 5 Moose Hill Pkwy, Sharon, MA 02067

Work

Position: Food Preparation and Serving Related Occupations

Education

Degree: Associate degree or higher

Emails

Resumes

Resumes

Andrew Camilli Photo 1

Co-Founder

View page
Location:
Boston, MA
Industry:
Higher Education
Work:
Howard Hughes Medical Institute Jul 2005 - Aug 2018
Investigator

Phagepro Jul 2005 - Aug 2018
Co-Founder

Tufts University School of Medicine Jul 2005 - Aug 2018
Professor

Harvard Medical School Sep 1992 - Jul 1995
Postdoctoral Research Fellow
Education:
University of Pennsylvania School of Medicine 1992
Doctorates, Doctor of Philosophy, Microbiology, Philosophy
University of Michigan College of Literature, Science, and the Arts 1987
Bachelors, Microbiology
Skills:
Molecular Biology
Microbiology
Molecular Cloning
Life Sciences
Bacteriophage Biology
Phage Therapy
Genomics
Andrew Camilli Photo 2

Professor

View page
Location:
Boston, MA
Industry:
Research
Work:
Howard Hughes Medical Institute
Professor
Education:
Howard Hughes Medical Institute

Business Records

Name / Title
Company / Classification
Phones & Addresses
Andrew Camilli
Research Faculty/staff Microbial Pathogenesis
Trustees of Tufts College Inc
University
711 Washington St, Boston, MA 02111
711 Washington St, Winchester, MA 02111
(617) 628-5000, (781) 729-1922

Publications

Us Patents

Cholera Vaccines

View page
US Patent:
8642046, Feb 4, 2014
Filed:
Oct 9, 2008
Appl. No.:
12/681951
Inventors:
Andrew Camilli - Sharon MA, US
Stefan Schild - Gratz, AT
Eric Jorge Nelson - Boston MA, US
Assignee:
Tufts University - Medford MA
International Classification:
A61K 39/116
US Classification:
4242031, 4242611, 4242521
Abstract:
The methods and compositions of the present invention are directed to a vaccine against comprised of outer membrane vesicles (OMVs). Such vaccines are relatively stable, facilitating distribution. Inventive methods generally include administration of a vaccine against by intranasal, intraperitoneal, oral or intragastric routes. Such vaccines confer immunity to the individual, and when administered to pregnant subjects, can be conferred to the offspring of individuals.

Systematic Identification Of Essential Genes By In Vitro Transposon Mutagenesis

View page
US Patent:
62073842, Mar 27, 2001
Filed:
Mar 26, 1999
Appl. No.:
9/277565
Inventors:
John J. Mekalanos - Cambridge MA
Brian J. Akerley - Brookline MA
Eric J. Rubin - Waban MA
Andrew Camilli - Sharon MA
Assignee:
The General Hospital Corporation - Boston MA
Trustees of Tufts College - Boston MA
President and Fellows of Harvard College - Cambridge MA
International Classification:
C12Q1/02;1/68
7
C12N15/74
15/63
15/85
US Classification:
435 6
Abstract:
The invention features a general system for the identification of essential genes in organisms. This system is applicable to the discovery of novel target genes for antimicrobial compounds, as well as to the discovery of genes that enhance cell growth or viability.

Selection Of Bacterial Genes Induced In Host Tissues

View page
US Patent:
55124526, Apr 30, 1996
Filed:
Sep 28, 1993
Appl. No.:
8/127905
Inventors:
John J. Mekalanos - Cambridge MA
Andrew Camilli - Chestnut Hill MA
Assignee:
President and Fellows of Harvard College - Cambridge MA
International Classification:
C12Q 102
C12N 1500
US Classification:
435 25
Abstract:
A reporter system relating to in vivo expression technology was devised to aid in the identification and study of genes that display temporal or spatial patterns of expression during infection of host tissues. The method of this invention comprises integrating a site-specific DNA recombinase expression vector, and a reporter gene that is permanently removable by the recombinase, by way of homologous recombination into a microorganism's chromosome and inducing the expression of a synthetic operon which encodes transcripts, the expression of which are easily monitored in vitro and which result in a permanent genetic change, excision of the reporter gene, that is heritable and easily detectable subsequent to induction of the synthetic operon.

Method Of Detecting Gene Expression

View page
US Patent:
55716881, Nov 5, 1996
Filed:
Feb 27, 1995
Appl. No.:
8/396415
Inventors:
John J. Mekalanos - Cambridge MA
Andrew Camilli - Chestnut Hill MA
International Classification:
C12Q 102
C12Q 104
C12Q 168
US Classification:
435 29
Abstract:
A reporter system relating to in vivo expression technology was devised to aid in the identification and study of genes that display temporal or spatial patterns of expression during infection of host tissues. The method of this invention comprises constructing a strain or pool of strains of a microorganism which contains an artificial cointegrate comprising a reporter gene flanked by direct repeats of sequences to which a resolvase enzyme binds, thus catalyzing excision of the reporter gene, and further contains a coding sequence under the control of a promoter sequence which encodes transcripts, the expression of which are easily monitored in vitro and which result in a permanent genetic change, excision of the reporter gene, that is heritable and easily detectable subsequent to induction of the synthetic operon.

Methods And Apparatus For Transformation Of Naturally Competent Cells

View page
US Patent:
20170051311, Feb 23, 2017
Filed:
May 1, 2015
Appl. No.:
15/308329
Inventors:
- MEDFORD MA, US
ANDREW CAMILLI - BOSTON MA, US
Assignee:
TUFTS UNIVERSITY - MEDFORD MA
International Classification:
C12N 15/90
Abstract:
The present invention includes compositions and methods of co-transformation of naturally competent cells. In one aspect of the invention, a method is included for introducing nucleic acid sequences into one or more naturally competent cells in parallel. In other aspects, a heterogenic pool of co-transformed naturally competent cells and an apparatus for introducing two or more populations of nucleic acid sequences into a population of naturally competent cells in parallel are also included.

Homopolymer Mediated Nucleic Acid Amplification

View page
US Patent:
20150203887, Jul 23, 2015
Filed:
Aug 23, 2013
Appl. No.:
14/423311
Inventors:
- Medford MA, US
Andrew Camilli - Sharon MA, US
Assignee:
Tufts University - Medford MA
International Classification:
C12P 19/34
Abstract:
According to some aspects of the invention, provided herein are methods of amplifying nucleic acids using homopolymer-dedicated ligation. The methods, in some embodiments, comprise adding a first homopolymer of at least 12 nucleotides to each 3′ end of blunt-ended double-stranded nucleic acid containing a target nucleic acid, thereby producing a partially double-stranded nucleic acid.
Andrew M Camilli from Sharon, MA, age ~61 Get Report